Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors
Accomplished business executive and attorney with diverse industry experience including over 20 years in life sciences and pharma with successful...
Accomplished business executive and attorney with diverse industry experience including over 20 years in life sciences and pharma with successful...
– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin®/ Macrilen™in Europe as the Company plans to pursue...
Biotech executive with robust experience in financial and corporate strategy and operational excellence will strengthen the company’s leadership teamLONDON, April...
SANTA CLARA, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated...
Local First Responders Help Raise Awareness and Funds During ALS Awareness MonthWESTBOROUGH, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- The...
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced...
BOTHELL, Wash., April 19, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, PhD, President and...
Results of “SPEED” study confirm the speed of diagnostic effectiveness of a single microdose array print (MAP™) spray using the...
ROCKAWAY, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore™ nVNS...
Company to begin hosting quarterly calls to provide broad updates across pipelineWATERTOWN, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Kymera...
FLORHAM PARK, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a...
Approval adds HPV to menu of tests available on Enzo’s GenFlex® platform, which includes COVID-19 PCR and CT/NG/TVNEW YORK, NY,...
Niclosamide Inhalation Powder Well Tolerated with No Serious Adverse Events Across All Subject Cohorts Current Data Suggests Niclosamide Inhalation Powder...
PRINCETON, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on...
Three ASCRS presentations will feature data from Nyxol® clinical studies: second Phase 3 MIRA-3 trial (reversal of mydriasis) and Phase...
SINGAPORE and SEOUL, South Korea, April 19, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company, focused on...
First event to feature Kettering Health, a leading enterprise breast care provider with 14 breast centers across southwest OhioNASHUA, N.H.,...
GCC19CART is an autologous CAR T therapy candidate that has shown promising results in over 30 R/R mCRC patients in...
Key Highlights: Immuron’s request for AU$5.4M (US$4M) additional funding from the U.S. Department of Defense for Travelan considered to be...
Preclinical data for lead investigational drug, HCW9218, in treatment of therapy-induced senescence in cancer Debut of preclinical data related to age-associated...